您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版) ›› 2011, Vol. 49 ›› Issue (2): 93-96.

• 论文 • 上一篇    下一篇

阿托伐他汀联合胺碘酮对双腔起搏患者心房颤动发生率的影响

魏子秀,张梅   

  1. 山东大学齐鲁医院心内科, 济南 250012
  • 收稿日期:2010-10-22 出版日期:2011-02-10 发布日期:2011-02-10
  • 通讯作者: 张梅,女,教授,博士生导师,研究方向为心血管疾病的无创伤性诊断和治疗。 E-mail:daixh@vip.sina.com
  • 作者简介:魏子秀(1978- ),女,博士研究生,研究方向为心律失常的药物及器械治疗。

Effect of Atorvastatin combined with Amiodarone on prevention of paroxysmal atrial fibrillation after dual-chamber-pacemaker implantation

WEI Zi-xiu, ZHANG Mei   

  1. Department of Cardiology, Qilu Hospital of Shandong University, Jinan 250012, China
  • Received:2010-10-22 Online:2011-02-10 Published:2011-02-10

摘要:

目的     观察阿托伐他汀和胺碘酮联用对病态窦房结综合征(SSS)患者双腔起搏后心房颤动(房颤)发生率的影响。方法    选取SSS并阵发性房颤(PAF)患者94例,双腔起搏器植入后随机分为对照组(n=46)和观察组(n=48),对照组常规治疗基础上给予胺碘酮口服;观察组在上述方案基础上加服阿托伐他汀20mg/d,疗程为12个月,观察房颤发生情况及血浆C反应蛋白(CRP)水平。结果    与对照组比较,观察组房颤的发作次数及持续时间、房颤治疗有效率、起搏器记录到的心房高频事件(AHREs)均显著低于对照组(P<0.05),且血浆CRP水平显著低于对照组(P<0.05)。结论    阿托伐他汀联合胺碘酮治疗可进一步降低双腔起搏患者房颤的发生,其机制可能与他汀类药物抑制炎症反应有关。

关键词: 病窦综合征;心房颤动;双腔起搏;胺碘酮;阿托伐他汀

Abstract:

Objective    To evaluate the effect of atorvastatin combined with amiodarone on preventing paroxysmal atrial fibrillation(PAF) following dual-chamber-pacemaker implantation in the patients with sick sinus syndrome(SSS).  Methods     Ninety-four SSS patients suffering from PAF after dual-chamber-pacemaker implantation were randomly divided into the treatment group and the control group. While the patients in the control group were given amiodarone only,  those in the treatment group were administrated with additional atorvastatin (20mg/day). After a 12-month followup, PAF times, AF duration and serum level of C-reactive protein(CRP) were observed. Results     PAF times, AF burden,  AHREs recorded by the pacemaker, the effectiveness of AF treatment and serum level of CRP in the treatment group were significantly lower than in the control group(P<0.05).  Conclusions     Atorvastatin combined with amiodarone can effectively inhibit the occurrence of PAF after dual-chamber-pacemaker implantation in patients with SSS. The mechanism may be attributed to the effect of atorvastatin to inhibit Inflammatory reaction.

Key words: Sick sinus syndrome; Atrial fibrillation; Dualchamber pacing; Amiodarone; Atorvastatin

中图分类号: 

  • R541.7
[1] 郑少华1,张玉娇1,李志远2,侯绪娟3,王曦敏1,段文昌4,侯应龙1. 持续性快速右心房起搏犬肺静脉-左心房连接处自主神经重构的研究[J]. 山东大学学报(医学版), 2013, 51(12): 7-10.
[2] 付开丽1,张学义2,朱萌3,王志浩1,王华1,钟明1,张运1,张薇1. 不同病因心房颤动患者卒中危险的评估[J]. 山东大学学报(医学版), 2013, 51(06): 61-63.
[3] 孙雪林1,2,卜培莉1,刘军妮1,曹广庆3,李丽4,于琼4. 心房颤动患者心房组织SIRT1表达与心房纤维化的相关性[J]. 山东大学学报(医学版), 2012, 50(9): 68-72.
[4] 胡科,陈良华,宋尚明,刘同宝. 主动脉窦造影及局部电生理特点的临床应用[J]. 山东大学学报(医学版), 2012, 50(7): 92-96.
[5] 王卫杰,张玉娇,高梅,王奖荣,侯应龙. 瑞舒伐他汀对心肌梗死兔心房结构重构的影响[J]. 山东大学学报(医学版), 2012, 50(4): 29-32.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!